ETS1 and prostate cancer: NR2F2 (COUP-TFII) plays a critical role in mediating the effects of DHA treatment on EFNB2, EBF1, ETS1, and VEGFA expression, and the knockdown of NR2F2 can recede the functional changes induced by DHA treatment in prostate cancer cells.